SG11201401084TA - Anti-viral compounds - Google Patents

Anti-viral compounds

Info

Publication number
SG11201401084TA
SG11201401084TA SG11201401084TA SG11201401084TA SG11201401084TA SG 11201401084T A SG11201401084T A SG 11201401084TA SG 11201401084T A SG11201401084T A SG 11201401084TA SG 11201401084T A SG11201401084T A SG 11201401084TA SG 11201401084T A SG11201401084T A SG 11201401084TA
Authority
SG
Singapore
Prior art keywords
viral compounds
viral
compounds
Prior art date
Application number
SG11201401084TA
Other languages
English (en)
Inventor
Shawn P Iadonato
Kristin Bedard
Myra Wang Imanaka
Kerry W Fowler
Original Assignee
Kineta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kineta Inc filed Critical Kineta Inc
Publication of SG11201401084TA publication Critical patent/SG11201401084TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG11201401084TA 2011-09-30 2012-09-27 Anti-viral compounds SG11201401084TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161542049P 2011-09-30 2011-09-30
PCT/US2012/057646 WO2013049407A2 (en) 2011-09-30 2012-09-27 Anti-viral compounds

Publications (1)

Publication Number Publication Date
SG11201401084TA true SG11201401084TA (en) 2014-04-28

Family

ID=47996748

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201401084TA SG11201401084TA (en) 2011-09-30 2012-09-27 Anti-viral compounds

Country Status (16)

Country Link
US (2) US9555106B2 (zh)
EP (1) EP2748172B1 (zh)
JP (2) JP2014528412A (zh)
KR (1) KR20140070631A (zh)
CN (1) CN103857683B (zh)
AP (1) AP2014007595A0 (zh)
AU (3) AU2012315953A1 (zh)
BR (1) BR112014007599A2 (zh)
CA (1) CA2859946C (zh)
HK (1) HK1199029A1 (zh)
IL (1) IL231780A (zh)
MX (1) MX351818B (zh)
SG (1) SG11201401084TA (zh)
TW (1) TW201326163A (zh)
WO (1) WO2013049407A2 (zh)
ZA (1) ZA201401825B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9555106B2 (en) 2011-09-30 2017-01-31 Kineta, Inc. Anti-viral compounds
US9073946B2 (en) * 2013-01-15 2015-07-07 Kineta, Inc. Anti-viral compounds
TW201623265A (zh) * 2014-05-09 2016-07-01 奇尼塔公司 抗病毒化合物、醫藥組合物及其使用方法
SG11201909516VA (en) 2017-04-14 2019-11-28 Tollnine Inc Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their use
CR20200618A (es) 2018-06-19 2021-01-21 Novartis Ag Derivados de tetrahidrotienopiridina n-sustituidos y sus usos
WO2020036574A1 (en) * 2018-08-17 2020-02-20 Kineta, Inc. Activators of the retinoic acid inducible gene "rig-i' pathway and methods of use thereof
WO2021174091A1 (en) 2020-02-28 2021-09-02 Tallac Therapeutics, Inc. Transglutaminase-mediated conjugation
JP2024508817A (ja) * 2021-02-24 2024-02-28 エフ． ホフマン－ラ ロシュ アーゲー Ｂ型肝炎ウイルス感染症の処置および予防のためのベンゾチアゾリルビシクロ［１．１．１］ペンタン誘導体

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3489558A (en) * 1967-09-18 1970-01-13 Ibm Photoconductive benzobisthiazoles and their use in electrophotographic processes
JPS60205454A (ja) * 1984-03-29 1985-10-17 Mitsubishi Paper Mills Ltd 電子写真感光体
JPS63190880A (ja) * 1986-09-09 1988-08-08 Nippon Tokushu Noyaku Seizo Kk 新規ｎ−ベンゾチアゾリル−アミド類及び殺虫剤
JPS63270608A (ja) * 1986-12-10 1988-11-08 Sumitomo Chem Co Ltd 種子消毒剤
US4940722A (en) * 1986-12-10 1990-07-10 Sumitomo Chemical Companmy, Limited Seed disinfectant composition
IL90337A0 (en) * 1988-05-24 1989-12-15 Pfizer Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents
AU687440B2 (en) * 1993-08-24 1998-02-26 Medivir Ab Compounds and methods for inhibition of HIV and related viruses
US6310211B1 (en) * 1996-09-10 2001-10-30 Pharmacia & Upjohn Company 8-hydroxy-7-substituted quinolines as anti-viral agents
ID30204A (id) * 1999-12-27 2001-11-15 Japan Tobacco Inc Senyawa-senyawa cincin terfusi dan penggunaannya sebagai obat
JP3972167B2 (ja) * 2000-01-26 2007-09-05 株式会社大塚製薬工場 ホスホン酸ジエステル誘導体
MXPA02007632A (es) * 2000-02-07 2004-08-23 Abbott Gmbh & Co Kg Derivados de 2-benzotiazolil urea y su uso como inhibidores de proteina cinasa.
US6660870B1 (en) * 2000-03-17 2003-12-09 Alcon, Inc. 2-acylaminobenzimidazole derivatives for treating glaucoma
US7122544B2 (en) * 2000-12-06 2006-10-17 Signal Pharmaceuticals, Llc Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
JP4038665B2 (ja) * 2002-06-19 2008-01-30 株式会社大塚製薬工場 ホスホン酸ジエステル誘導体
WO2004078115A2 (en) * 2003-02-28 2004-09-16 Viropharma, Incorporated Benzothiazole compounds, compositions and methods for treatment and prophylaxis of rotavirus infections and associated diseases
ES2423800T3 (es) * 2003-03-28 2013-09-24 Novartis Vaccines And Diagnostics, Inc. Uso de compuestos orgánicos para la inmunopotenciación
EP1680431A1 (en) * 2003-10-17 2006-07-19 Rigel Pharmaceuticals, Inc. Benzothiazole and thiazole'5,5-b!pyridine compositions and their use as ubiquitin ligase inhibitors
CN101031567B (zh) * 2004-09-20 2011-12-21 4Sc股份有限公司 新型杂环NF-κB抑制剂
US20100267717A1 (en) * 2005-07-29 2010-10-21 4Sc Ag Novel Heterocyclic NF-kB Inhibitors
GB0421908D0 (en) * 2004-10-01 2004-11-03 Angeletti P Ist Richerche Bio New uses
AU2006244203B2 (en) * 2005-05-09 2012-05-03 Achillion Pharmaceuticals, Inc. Thiazole compounds and methods of use
KR20080059634A (ko) * 2005-10-06 2008-06-30 유니버시티 오브 매사추세츠 Ｈｉｖ 복제를 억제하기 위한 시약의 조성물 및 합성법
BRPI0619733A2 (pt) * 2005-12-12 2011-10-11 Genelabs Tech Inc compostos antivirais de n-(anel aromático de 6 membros)-amido
EA200801838A1 (ru) * 2006-03-15 2009-02-27 4ЭсЦэ АГ НОВЫЕ ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ NF-kB
CN101528744A (zh) * 2006-10-20 2009-09-09 Irm责任有限公司 用于调节c-kit和pdgfr受体的组合物和方法
WO2008141385A1 (en) * 2007-05-21 2008-11-27 Biota Scientific Management Pty Ltd Viral polymerase inhibitors
CN101678107A (zh) * 2007-08-03 2010-03-24 萨米特公开有限公司 用于治疗杜兴型肌营养不良的药物组合物
UA100527C2 (en) * 2007-10-10 2013-01-10 Астразенека Аб Benzothiazoles as ghrelin receptor modulators
EP2311842A3 (en) * 2008-06-24 2011-07-13 Takeda Pharmaceutical Company Limited PI3K/M TOR inhibitors
WO2010024903A1 (en) * 2008-08-29 2010-03-04 Yangbo Feng BENZO[d]OXAZOLES AND BENZO[d]THIAZOLES AS KINASE INHIBITORS
GB0820856D0 (en) * 2008-11-14 2008-12-24 Univ Leuven Kath Novel inhibitors of flavivirus replication
PA8854001A1 (es) * 2008-12-16 2010-07-27 Abbott Lab Compuestos novedosos como ligandos de receptores de canabinoides
AP3069A (en) * 2009-02-27 2014-12-31 Siga Technologies Inc Thienopyridine derivatives for the treatment and prvention of dengue virus infection
WO2010100144A1 (en) * 2009-03-04 2010-09-10 Merck Serono S.A. Fused bicyclic compounds as inhibitors for pi3 kinase
US8338441B2 (en) * 2009-05-15 2012-12-25 Gilead Sciences, Inc. Inhibitors of human immunodeficiency virus replication
WO2010144909A1 (en) * 2009-06-12 2010-12-16 Novartis Ag Fused heterocyclic compounds and their uses
JP2012532102A (ja) 2009-06-30 2012-12-13 シガ・テクノロジーズ・インコーポレーテッド デングウイルス感染の治療法および予防法
WO2011006158A2 (en) * 2009-07-10 2011-01-13 University Of Maryland, Baltimore Targeting nad biosynthesis in bacterial pathogens
WO2011022721A1 (en) * 2009-08-21 2011-02-24 Microbiotix, Inc Inhibitors of botulinum neurotoxins
US9555106B2 (en) 2011-09-30 2017-01-31 Kineta, Inc. Anti-viral compounds

Also Published As

Publication number Publication date
CN103857683A (zh) 2014-06-11
CN103857683B (zh) 2016-10-12
AP2014007595A0 (en) 2014-04-30
ZA201401825B (en) 2017-08-30
AU2017254812A1 (en) 2017-11-16
MX2014003887A (es) 2014-11-21
EP2748172A2 (en) 2014-07-02
MX351818B (es) 2017-10-30
US20140227320A1 (en) 2014-08-14
HK1199029A1 (zh) 2015-06-19
US9555106B2 (en) 2017-01-31
KR20140070631A (ko) 2014-06-10
WO2013049407A3 (en) 2013-05-30
CA2859946A1 (en) 2013-04-04
AU2017210483A1 (en) 2017-08-17
JP2017222656A (ja) 2017-12-21
EP2748172A4 (en) 2015-10-14
JP2014528412A (ja) 2014-10-27
US20170258897A1 (en) 2017-09-14
NZ622636A (en) 2016-07-29
AU2012315953A1 (en) 2014-04-03
EP2748172B1 (en) 2017-12-06
BR112014007599A2 (pt) 2017-04-11
US9956285B2 (en) 2018-05-01
WO2013049407A2 (en) 2013-04-04
AU2017254812B2 (en) 2018-07-19
IL231780A0 (en) 2014-05-28
IL231780A (en) 2017-08-31
TW201326163A (zh) 2013-07-01
CA2859946C (en) 2019-11-05

Similar Documents

Publication Publication Date Title
IL243558A0 (en) Substances with antiviral activity and the use of preparations containing them
IL222634A0 (en) Anti-viral compounds
EP2651920A4 (en) ANTI-VIRAL COMPOUNDS
GB201109763D0 (en) Compounds
GB201106395D0 (en) Compounds
IL222633A0 (en) Anti-viral compounds
EP2651926A4 (en) ANTI-VIRAL COMPOUNDS
EP2560636A4 (en) ANTIVIRAL COMPOUNDS
EP2651927A4 (en) ANTIVIRAL CONNECTIONS
EP2651928A4 (en) ANTI-VIRAL COMPOUNDS
GB201107197D0 (en) Compounds
EP2651923A4 (en) ANTI-VIRAL COMPOUNDS
EP2651925A4 (en) ANTI-VIRAL COMPOUNDS
IL222635A0 (en) Anti-viral compounds
HK1199029A1 (zh) 抗病毒化合物
EP2714693A4 (en) ANTIVIRAL COMPOUNDS
EP2714035A4 (en) ANTIVIRAL CONNECTIONS
EP2560635A4 (en) ANTIVIRAL CONNECTIONS
GB201110938D0 (en) Compounds
GB201105659D0 (en) Compounds
ZA201903284B (en) Anti-viral compounds
EP2560628A4 (en) ANTIVIRAL CONNECTIONS
GB201107348D0 (en) Novel anti-viral
GB201115829D0 (en) Compounds
GB201115828D0 (en) Compounds